IDL Diagnostics AB (FRA:80R) E10: €-0.02 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:80R IDL Diagnostics AB FRA:80R
55 GF Score
Price €0.03
GF Value €0.03
! 2 Warning Signs
View Full Analysis

What is IDL Diagnostics AB E10?

IDL Diagnostics AB FRA:80R +5.79% 55 E10 is €-0.02 as of Mar. 2026. GuruFocus rates FRA:80R with a GF Score™ of 55/100 and a GF Value™ of €0.03. The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

IDL Diagnostics AB's adjusted earnings per share data for the three months ended in Mar. 2026 was €0.001. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €-0.02 for the trailing ten years ended in Mar. 2026.

During the past 3 years, the average E10 Growth Rate was 0.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of IDL Diagnostics AB was 27.40% per year. The lowest was 0.70% per year. And the median was 14.05% per year.

As of today (2026-07-15), IDL Diagnostics AB's current stock price is €0.0256. IDL Diagnostics AB's E10 for the quarter that ended in Mar. 2026 was €-0.02. IDL Diagnostics AB's Shiller PE Ratio of today is .


IDL Diagnostics AB  (FRA:80R) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


IDL Diagnostics AB E10 Related Terms


IDL Diagnostics AB E10 Historical Data

* Premium members only.

The historical data trend for IDL Diagnostics AB's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

IDL Diagnostics AB E10 Chart

IDL Diagnostics AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.12 -0.04 -0.03 0.00 -0.02

IDL Diagnostics AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.03 -0.03 -0.03 -0.02 -0.02

FRA:80R vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, IDL Diagnostics AB's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


IDL Diagnostics AB Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, IDL Diagnostics AB's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where IDL Diagnostics AB's Shiller PE Ratio falls into.


FRA:80R
55GF Score
IDL Diagnostics AB FRA:80R
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

IDL Diagnostics AB E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, IDL Diagnostics AB's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.001/133.5600*133.5600
=0.001

Current CPI (Mar. 2026) = 133.5600.

IDL Diagnostics AB Quarterly Data

per share eps CPI Adj_EPS
201606 -0.007 101.019 -0.009
201609 -0.009 101.138 -0.012
201612 -0.006 102.022 -0.008
201703 -0.015 102.022 -0.020
201706 -0.012 102.752 -0.016
201709 -0.013 103.279 -0.017
201712 -0.019 103.793 -0.024
201803 -0.014 103.962 -0.018
201806 -0.016 104.875 -0.020
201809 -0.013 105.679 -0.016
201812 -0.013 105.912 -0.016
201903 -0.011 105.886 -0.014
201906 -0.011 106.742 -0.014
201909 -0.010 107.214 -0.012
201912 -0.015 107.766 -0.019
202003 -0.007 106.563 -0.009
202006 -0.007 107.498 -0.009
202009 -0.008 107.635 -0.010
202012 -0.006 108.296 -0.007
202103 -0.008 108.360 -0.010
202106 -0.009 108.928 -0.011
202109 -0.020 110.338 -0.024
202112 -0.018 112.486 -0.021
202203 -0.009 114.825 -0.010
202206 -0.007 118.384 -0.008
202209 -0.005 122.296 -0.005
202212 -0.007 126.365 -0.007
202303 -0.005 127.042 -0.005
202306 -0.006 129.407 -0.006
202309 -0.005 130.224 -0.005
202312 -0.006 131.912 -0.006
202403 -0.004 132.205 -0.004
202406 -0.005 132.716 -0.005
202409 0.000 132.304 0.000
202412 0.000 132.987 0.000
202503 -0.001 132.825 -0.001
202506 -0.005 133.699 -0.005
202509 -0.001 133.480 -0.001
202512 -0.001 133.390 -0.001
202603 0.001 133.560 0.001

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of €-0.02 mean?
IDL Diagnostics AB (FRA:80R) has a E10 of €-0.02 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on IDL Diagnostics AB and its competitors.
Is IDL Diagnostics AB's E10 too high?
IDL Diagnostics AB's current E10 is €-0.02. Overall, IDL Diagnostics AB has a GF Score™ of 55/100, reflecting its overall financial health beyond just this single metric.
How does IDL Diagnostics AB's E10 compare to TMO and DHR?
IDL Diagnostics AB's E10 of €-0.02 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on IDL Diagnostics AB and its competitors. IDL Diagnostics AB's current E10 is €-0.02. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is IDL Diagnostics AB stock overvalued right now?
IDL Diagnostics AB (FRA:80R) has a current E10 of €-0.02. The stock's GF Value™ is €0.03, compared to a current price of €0.03 — trading 14.7% below its estimated fair value. The current E10 is €-0.02. IDL Diagnostics AB's overall GF Score™ is 55/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For IDL Diagnostics AB (FRA:80R), the current E10 is €-0.02 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is IDL Diagnostics AB (FRA:80R) Overvalued in 2026?

Based on GuruFocus' analysis, IDL Diagnostics AB stock appears to be undervalued. The current stock price of €0.03 is trading 14.7% below its estimated GF Value™ of €0.03.

Key valuation signals for FRA:80R:

  • E10: €-0.02
  • GF Value™: €0.03 vs. price of €0.03 (14.7% below fair value)
  • GF Score™: 55/100 with 2 warning signs

No single metric tells the full story. See the FRA:80R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


IDL Diagnostics AB Business Description

Other Exchanges IDLDX:Sweden
Address Karlsbodavagen 39, Bromma, Stockholm, SWE, 168 67
IDL Diagnostics AB is a Swedish company that develops and markets blood and urine sample tests. It specializes in oncology and bacteriology. The company has a broad product portfolio, is used in healthcare, and is established in various markets. In oncology, IDL Diagnostics uses various biomarkers, TK1 and cytokeratins, to support the treatment of cancers such as breast, prostate, and bladder cancers.
55GF Score

Get the complete analysis for FRA:80R

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.03
Price
€0.03
GF Value